Amisulpride in the treatment of fibromyalgia: an uncontrolled study.

Clinical rheumatology 20120901

Plasma amisulpride in relation to prescribed dose, clozapine augmentation, and other factors: data from a therapeutic drug monitoring service, 2002-2010.

Human psychopharmacology 20120901

Risperidone augmentation with amisulpride: the blue-tongue sign.

Psychiatry and clinical neurosciences 20120801

A validation of cognitive biomarkers for the early identification of cognitive enhancing agents in schizotypy: a three-center double-blind placebo-controlled study.

European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20120701

Changes in sexual function and gonadal axis hormones after switching to aripiprazole in male schizophrenia patients: a prospective pilot study.

International clinical psychopharmacology 20120701

Effects of drop-out on efficacy estimates in five Cochrane reviews of popular antipsychotics for schizophrenia.

Acta psychiatrica Scandinavica 20120701

Antipsychotic monotherapy and polypharmacy in the treatment of outpatients with schizophrenia in the European Schizophrenia Outpatient Health Outcomes Study.

The Journal of nervous and mental disease 20120701

Amisulpride-induced acute akathisia in OCD: an example of dysfunctional dopamine-serotonin interactions?

Journal of psychopharmacology (Oxford, England) 20120601

Cost-effectiveness analysis of burning mouth syndrome therapy.

Community dentistry and oral epidemiology 20120401

Effect of the antipsychotic agent amisulpride on glucose lowering and insulin secretion.

Diabetes, obesity & metabolism 20120401

BMP inhibition by DAN in Hensen's node is a critical step for the establishment of left-right asymmetry in the chick embryo.

Developmental biology 20120301

No negative symptoms in healthy volunteers after single doses of amisulpride, aripiprazole, and haloperidol: a double-blind placebo-controlled trial.

International clinical psychopharmacology 20120301

Relationship between prolactin levels and subjective endocrine-related adverse effects in patients with schizophrenia receiving long-term treatment with amisulpride.

Pharmacopsychiatry 20120301

Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia.

Translational psychiatry 20120301

Hyperprolactinemia induced by low-dosage amisulpride in Korean psychiatric patients.

Psychiatry and clinical neurosciences 20120201

Temporal lobe epilepsy masquerading as psychosis--a case report and literature review.

Neurocase 20120101

Attentional and emotional functioning in schizophrenia patients treated with conventional and atypical antipsychotic drugs.

Medical science monitor : international medical journal of experimental and clinical research 20120101

Identification of photodegradation product of amisulpride by ultra-high-pressure liquid chromatography-DAD/ESI-quadrupole time-of-flight-mass spectrometry.

Journal of pharmaceutical and biomedical analysis 20111215

Amisulpride versus moclobemide in treatment of clozapine-induced hypersalivation.

The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 20111201

The acute and long-term effectiveness of amisulpride in patients with schizophrenia: results of a 12-month open-label prospective follow-up study.

Human psychopharmacology 20111201

Antiserotonergic antipsychotics are associated with obsessive-compulsive symptoms in schizophrenia.

Psychological medicine 20111101

Secondary pseudomyopia induced by amisulpride.

Optometry and vision science : official publication of the American Academy of Optometry 20111101

Response perseveration in stimulant dependence is associated with striatal dysfunction and can be ameliorated by a D(2/3) receptor agonist.

Biological psychiatry 20111015

Differential effects of amisulpride and haloperidol on dopamine D2 receptor-mediated signaling in SH-SY5Y cells.

Neuropharmacology 20110901

Amisulpride in the treatment of somatoform disorders.

The Australian and New Zealand journal of psychiatry 20110901

Basic drug analysis by strong cation-exchange liquid chromatography-tandem mass spectrometry: simultaneous analysis of amisulpride, and of metamfetamine and amfetamine in serum/plasma.

Biomedical chromatography : BMC 20110801

Prediction of torsade de pointes from the QT interval: analysis of a case series of amisulpride overdoses.

Clinical pharmacology and therapeutics 20110801

Clozapine-induced salivation: interaction with N-desmethylclozapine and amisulpride in an experimental rat model.

European journal of oral sciences 20110801

Beta-glucan from Saccharomyces cerevisiae reduces plasma lipid peroxidation induced by haloperidol.

International journal of biological macromolecules 20110701

Efficacy of antipsychotic drugs against hostility in the European First-Episode Schizophrenia Trial (EUFEST).

The Journal of clinical psychiatry 20110701

Augmentation treatment with amisulpride in schizophrenic patients partially responsive to olanzapine.

Pharmacopsychiatry 20110601

Safety of amisulpride in combination with antidepressants under common clinical practice conditions.

International journal of psychiatry in clinical practice 20110601

Amisulpride-induced seizurogenic effect: a potential role of opioid receptor-linked transduction systems.

Basic & clinical pharmacology & toxicology 20110501

Estimation of rac-amisulpride transfer into milk and of infant dose via milk during its use in a lactating woman with bipolar disorder and schizophrenia.

Breastfeeding medicine : the official journal of the Academy of Breastfeeding Medicine 20110401

The effectiveness of the combination therapy of amisulpride and quetiapine for managing treatment-resistant schizophrenia: a naturalistic study.

Journal of clinical psychopharmacology 20110401

Amisulpride vs. fluoxetine treatment of chronic fatigue syndrome: a pilot study.

European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20110301

Hyperprolactinaemia with amisulpride.

Psychiatria Danubina 20110301

Dopamine-mediated reinforcement learning signals in the striatum and ventromedial prefrontal cortex underlie value-based choices.

The Journal of neuroscience : the official journal of the Society for Neuroscience 20110202

Clock genes and body composition in patients with schizophrenia under treatment with antipsychotic drugs.

Schizophrenia research 20110201

Amisulpride therapeutic dose-induced asymptomatic bradycardia.

Progress in neuro-psychopharmacology & biological psychiatry 20110115

Second-generation antipsychotics in major depressive disorder: update and clinical perspective.

Current opinion in psychiatry 20110101

Risperidone versus other atypical antipsychotics for schizophrenia.

The Cochrane database of systematic reviews 20110101

[Amisulpride for the treatment of alcohol dependence].

Adicciones 20110101

Amisulpride augmentation of clozapine in refractory schizophrenia.

The Journal of neuropsychiatry and clinical neurosciences 20110101

Amisulpride and neuroleptic malignant syndrome.

Chang Gung medical journal 20110101

Second-generation antipsychotics for major depressive disorder and dysthymia.

The Cochrane database of systematic reviews 20101208

Assessment of infant dose through milk in a lactating woman taking amisulpride and desvenlafaxine for treatment-resistant depression.

Therapeutic drug monitoring 20101201

Head-to-head comparisons of metabolic side effects of second generation antipsychotics in the treatment of schizophrenia: a systematic review and meta-analysis.

Schizophrenia research 20101101

Relief from chronic intractable auditory hallucinations after long-term bilateral theta burst stimulation.

The American journal of psychiatry 20101101

Hyperprolactinaemia and acute psychosis: prolactinoma or medication-induced phenomenon?

The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 20100801

Amisulpride overdose is frequently associated with QT prolongation and torsades de pointes.

Journal of clinical psychopharmacology 20100801

Celecoxib treatment in an early stage of schizophrenia: results of a randomized, double-blind, placebo-controlled trial of celecoxib augmentation of amisulpride treatment.

Schizophrenia research 20100801

Familial differential treatment response in schizophrenia--lessons from a case of three affected siblings.

Pharmacopsychiatry 20100701

Tardive dystonia induced by switch of atypical antipsychotics.

Pharmacopsychiatry 20100701

Amisulpride overdose: suggested management of prolonged QTc.

Emergency medicine journal : EMJ 20100701

Dual motor response to l-dopa and nociceptin/orphanin FQ receptor antagonists in 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP) treated mice: Paradoxical inhibition is relieved by D(2)/D(3) receptor blockade.

Experimental neurology 20100601

Neuroleptic malignant syndrome.

The Australian and New Zealand journal of psychiatry 20100601

Influence of compulsivity of drug abuse on dopaminergic modulation of attentional bias in stimulant dependence.

Archives of general psychiatry 20100601

Gender, psychosis and psychotropic drugs: differences and similarities.

Psychiatria Danubina 20100601

Amisulpride-induced tardive dyskinesia in childhood onset schizophrenia.

Progress in neuro-psychopharmacology & biological psychiatry 20100530

Drug attitude as predictor for effectiveness in first-episode schizophrenia: Results of an open randomized trial (EUFEST).

European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20100501

Amisulpride monotherapy in a patient with clozapine-resistant schizophrenia.

Clinical neuropharmacology 20100501

[Prolonged QT interval in two cases of amisulpride overdose].

Medicina clinica 20100424

Antipsychotic medication, functional outcome and quality of life in schizophrenia: focus on amisulpride.

Current medical research and opinion 20100401

Amisulpride-induced tardive dystonia: a case report.

Progress in neuro-psychopharmacology & biological psychiatry 20100317

Effects of amisulpride on emotional memory using a dual-process model in healthy male volunteers.

Journal of psychopharmacology (Oxford, England) 20100301

Torsade de pointes associated with low-dose amisulpride: a case report.

Journal of psychopharmacology (Oxford, England) 20100301

Inhibitory effects of polyphenol compounds on lipid peroxidation caused by antipsychotics (haloperidol and amisulpride) in human plasma in vitro.

The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 20100301

Acute rhabdomyolysis during treatment with amisulpride and metformin.

European journal of clinical pharmacology 20100301

Amisulpride versus olanzapine in the treatment of schizophrenia in Indian patients: randomized controlled trial.

The Australian and New Zealand journal of psychiatry 20100301

The effects of psychopathology on subjective experience of side effects of antipsychotics in patients with schizophrenia.

International clinical psychopharmacology 20100301

Reduced serum BDNF levels in patients with chronic schizophrenic disorder in relapse, who were treated with typical or atypical antipsychotics.

The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 20100301

A tryptamine-derived catecholaminergic enhancer, (-)-1-(benzofuran-2-yl)-2-propylaminopentane [(-)-BPAP], attenuates reinstatement of methamphetamine-seeking behavior in rats.

Neuroscience 20100120

Amisulpride versus other atypical antipsychotics for schizophrenia.

The Cochrane database of systematic reviews 20100101

An ethical dilemma: decision making about liver transplantation in a patient with schizophrenia.

Gastroenterology nursing : the official journal of the Society of Gastroenterology Nurses and Associates 20100101

Olanzapine versus other atypical antipsychotics for schizophrenia.

The Cochrane database of systematic reviews 20100101

Development and validation of spectrophotometric methods for estimating amisulpride in pharmaceutical preparations.

Analytical sciences : the international journal of the Japan Society for Analytical Chemistry 20100101

Successful treatment with amisulpride for poststroke psychosis.

The Journal of neuropsychiatry and clinical neurosciences 20100101

Possible rabbit syndrome with amisulpride.

The Journal of neuropsychiatry and clinical neurosciences 20100101

Amisulpride may worsen dyskinesia and trigger new-onset dyskinetic movements.

The Journal of neuropsychiatry and clinical neurosciences 20100101

Pisa syndrome during amisulpride treatment.

The Journal of neuropsychiatry and clinical neurosciences 20100101

Psychotic disorder as a manifestation of Graves' disease.

Psychosomatics 20100101

Quetiapine combined with amisulpride in schizophrenic patients with insufficient responses to quetiapine monotherapy.

Clinical neuropharmacology 20100101

Tardive oculogyric crisis associated with amisulpride monotherapy.

Journal of postgraduate medicine 20100101

Treatment with amisulpride of addicted patients to psychoactive substances and psychotic symptoms.

Actas espanolas de psiquiatria 20100101

Amisulpride - dose, plasma concentration, occupancy and response: implications for therapeutic drug monitoring.

Acta psychiatrica Scandinavica 20091201

Improved body weight and metabolic outcomes in overweight or obese psychiatric patients switched to amisulpride from other atypical antipsychotics.

Journal of clinical psychopharmacology 20091201

Amisulpride-induced mania with interictal psychosis.

Progress in neuro-psychopharmacology & biological psychiatry 20091113

Early- and delayed antipsychotic response and prediction of outcome in 528 severely impaired patients with schizophrenia treated with amisulpride.

Pharmacopsychiatry 20091101

Study on the efficacy and tolerability of amisulpride in medical/surgical inpatients with delirium admitted to a general hospital.

European psychiatry : the journal of the Association of European Psychiatrists 20091001

Low-dose amisulpride induced Pisa syndrome in an alcohol-dependent patient with liver cirrhosis.

Progress in neuro-psychopharmacology & biological psychiatry 20090831

Hyperprolactinemia and possibly related development of prolactinoma during amisulpride treatment; three cases.

Journal of psychopharmacology (Oxford, England) 20090801

Amisulpride treatment of adolescent patients with schizophrenia or schizo-affective disorders.

European child & adolescent psychiatry 20090801

Amisulpride is a potent 5-HT7 antagonist: relevance for antidepressant actions in vivo.

Psychopharmacology 20090701

Causal model of insight and psychopathology based on the PANSS factors: 1-year cross-sectional and longitudinal revalidation.

International clinical psychopharmacology 20090701

Targeting cognition in schizophrenia research: from etiology to treatment.

The American journal of psychiatry 20090601

Amisulpride doses and plasma levels in different age groups of patients with schizophrenia or schizoaffective disorder.

Journal of psychopharmacology (Oxford, England) 20090501

Amisulpride for the treatment of very-late-onset schizophrenia-like psychosis.

International journal of geriatric psychiatry 20090501

Akathisia and second-generation antipsychotic drugs.

Current opinion in psychiatry 20090501

Successful treatment with amisulpride for the progression of olfactory reference syndrome to schizophrenia.

Progress in neuro-psychopharmacology & biological psychiatry 20090430

Neurocognitive effectiveness of haloperidol, risperidone, and olanzapine in first-episode psychosis: a randomized, controlled 1-year follow-up comparison.

The Journal of clinical psychiatry 20090421

A pilot study of the safety and efficacy of amisulpride and risperidone in elderly psychotic patients.

European psychiatry : the journal of the Association of European Psychiatrists 20090401

Aripiprazole in combination with other antipsychotic drugs may worsen psychosis.

Journal of clinical pharmacy and therapeutics 20090401

Changes in neurocognitive function in patients with schizophrenia after starting or switching to amisulpride in comparison with the normal controls.

Journal of clinical psychopharmacology 20090401

Amisulpride treatment for clozapine-induced sialorrhea.

Journal of clinical psychopharmacology 20090401

Catatonia, neuroleptics and brain damage--a case report.

Journal of psychopharmacology (Oxford, England) 20090301

A flow-cytometric method to investigate glutamate-receptor-sensitivity in whole blood platelets - results from healthy controls and patients with schizophrenia.

Journal of psychiatric research 20090301

Is second-generation antipsychotic-induced hyperprolactinemia due to biologically active prolactin or to biologically inactive macroprolactin? Results from a prospective study.

The Journal of clinical psychiatry 20090201

Urinary incontinence associated with amisulpride.

The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 20090101

Combined treatment with amisulpride in patients with schizophrenia discharged from a short-term hospitalization unit: a 1-year retrospective study.

Clinical neuropharmacology 20090101

Amisulpride and galactorrhoea: delayed or withdrawal?

The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 20090101

Hyperpigmentation with amisulpride.

The Australian and New Zealand journal of psychiatry 20090101

Amisulpride-induced tardive dyskinesia and possible association of dyskinesia with hypothyroidism.

The Journal of neuropsychiatry and clinical neurosciences 20090101

Comparative bioavailability study of amisulpride tablets in healthy Indian volunteers.

Arzneimittel-Forschung 20090101

Clozapine combined with different antipsychotic drugs for treatment resistant schizophrenia.

The Cochrane database of systematic reviews 20090101

The 5-HT2 receptor profiles of antipsychotics in the pathogenesis of obsessive-compulsive symptoms in schizophrenia.

Clinical neuropharmacology 20090101

Evaluation of antidepressant like property of amisulpride per se and its comparison with fluoxetine and olanzapine using forced swimming test in albino mice.

Acta poloniae pharmaceutica 20090101

Tardive dyskinesia in a patient treated with quetiapine.

The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 20090101

Ziprasidone versus other atypical antipsychotics for schizophrenia.

The Cochrane database of systematic reviews 20090101

Adjunctive low-dose amisulpride in motor conversion disorder.

Clinical neuropharmacology 20090101

Amisulpride for clozapine induced sialorrhea.

Psychopharmacology bulletin 20090101

Liquid chromatography tandem mass spectrometry method for the quantification of amisulpride with LLOQ of 100 pg/mL using 100 microL of plasma.

Biomedical chromatography : BMC 20081201

Antipsychotics possessing antidepressive efficacy increase Golf protein in rat striatum.

Psychopharmacology 20081201

Subnanomolar dopamine D3 receptor antagonism coupled to moderate D2 affinity results in favourable antipsychotic-like activity in rodent models: II. behavioural characterisation of RG-15.

Naunyn-Schmiedeberg's archives of pharmacology 20081101

Subnanomolar dopamine D3 receptor antagonism coupled to moderate D2 affinity results in favourable antipsychotic-like activity in rodent models: I. neurochemical characterisation of RG-15.

Naunyn-Schmiedeberg's archives of pharmacology 20081101

Amisulpride the 'atypical' atypical antipsychotic--comparison to haloperidol, risperidone and clozapine.

Schizophrenia research 20081001

Tardive dystonia associated with low-dose of amisulpride: a case report.

Journal of clinical psychopharmacology 20081001

Weight gain in a patient with schizophrenia switched from quetiapine to amisulpride.

Psychiatry and clinical neurosciences 20081001

Aripiprazole resolves amisulpride and ziprasidone-induced hyperprolactinemia.

Psychiatry and clinical neurosciences 20081001

Striatal D2/D3 receptor occupancy, clinical response and side effects with amisulpride: an iodine-123-iodobenzamide SPET study.

Pharmacopsychiatry 20080901

Repeated acute dystonia following administration of amisulpride and ziprasidone in a patient with iron deficiency.

Progress in neuro-psychopharmacology & biological psychiatry 20080801

Clozapine-induced myocarditis after long-term treatment: case presentation and clinical perspectives.

Journal of psychopharmacology (Oxford, England) 20080701

Combination therapy with amisulpride and antidepressants: clinical observations in case series of elderly patients with psychotic depression.

Progress in neuro-psychopharmacology & biological psychiatry 20080701

Amisulpride improves obsessive-compulsive symptoms in schizophrenia patients taking atypical antipsychotics: an open-label switch study.

Journal of clinical psychopharmacology 20080601

Amisulpride-induced both oculogyric crisis and trismus.

Indian journal of medical sciences 20080601

Is aripiprazole the only choice of treatment of the patients who developed anti-psychotic agents-induced leucopenia and neutropenia? A case report.

Journal of psychopharmacology (Oxford, England) 20080501

Amisulpride-induced dystonia.

The Australian and New Zealand journal of psychiatry 20080501

Enantioselective analysis of amisulpride in pharmaceutical formulations by means of capillary electrophoresis.

Journal of pharmaceutical and biomedical analysis 20080414

Fatality due to amisulpride toxicity: a case report.

Medicine, science, and the law 20080401

Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomised clinical trial.

Lancet (London, England) 20080329

Comparing the use and discontinuation of antipsychotics in clinical practice: an observational study.

The Journal of clinical psychiatry 20080201

[Malignant neuroleptic syndrome associated with amisulpride].

Der Nervenarzt 20080101

Two-year study of relapse prevention by a new education program in schizophrenic patients treated with the same antipsychotic drug.

European psychiatry : the journal of the Association of European Psychiatrists 20080101

Amisulpride augmentation in patients with schizophrenia partially responsive or unresponsive to clozapine. A randomized, double-blind, placebo-controlled trial.

Pharmacopsychiatry 20080101

Worsening of psychosis in a 30 year old man with undifferentiated schizophrenia.

Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists 20080101

Cabergoline-induced psychotic exacerbation in schizophrenic patients.

General hospital psychiatry 20080101

Practical issues with amisulpride in the management of patients with schizophrenia.

Clinical drug investigation 20080101

Heart rate variability in schizophrenic patients switched from typical antipsychotic agents to amisulpride and olanzapine. 3-month follow-up.

Neuropsychobiology 20080101

Neuroleptic malignant syndrome without fever after addition of oxcarbazepine to long-term treatment with amisulpride.

General hospital psychiatry 20080101

[Costs of treatment in patients with schizophrenia switched to amisulpride--one-year follow-up].

Psychiatria Hungarica : A Magyar Pszichiatriai Tarsasag tudomanyos folyoirata 20080101

Serum creatine kinase elevation associated with olanzapine treatment.

BMJ case reports 20080101

Acute effects of treatment for prodromal symptoms for people putatively in a late initial prodromal state of psychosis.

The British journal of psychiatry. Supplement 20071201

Differences in the effect of second-generation antipsychotics on prolactinaemia: six weeks open-label trial in female in-patients.

Neuro endocrinology letters 20071201

Therapeutic drug monitoring for optimizing amisulpride therapy in patients with schizophrenia.

Journal of psychiatric research 20071001

The use of atypical antipsychotics in French psychiatric hospitals.

Pharmacy world & science : PWS 20071001

Treatment with amisulpride and olanzapine improve neuropsychological function in schizophrenia.

Human psychopharmacology 20071001

Amisulpride versus risperidone in the treatment of depression in patients with schizophrenia: a randomized, open-label, controlled trial.

Progress in neuro-psychopharmacology & biological psychiatry 20071001

Clozapine and amisulpride in refractory schizophrenia and alcohol dependence.

Journal of clinical psychopharmacology 20071001

Increase in plasma concentration of amisulpride after addition of concomitant lithium.

Journal of clinical psychopharmacology 20071001

The role of dopamine in attentional and memory biases for emotional information.

The American journal of psychiatry 20071001

Prevalence of hyperprolactinaemia in a naturalistic cohort of schizophrenia and bipolar outpatients during treatment with typical and atypical antipsychotics.

Journal of psychopharmacology (Oxford, England) 20070901

[Gilles-de-la-Tourette Syndrome as a Tardive Dyskinesia].

Psychiatrische Praxis 20070701

Alterations of glucose metabolism during treatment with clozapine or amisulpride: results from a prospective 16-week study.

Journal of psychopharmacology (Oxford, England) 20070601

A preliminary fMRI study of the effects on cortical activation of the treatment of refractory auditory hallucinations with rTMS.

Psychiatry research 20070515

Comparative validation of amisulpride determination in pharmaceuticals by several chromatographic, electrophoretic and spectrophotometric methods.

Analytica chimica acta 20070508

Blockade of morphine-induced behavioral sensitization by a combination of amisulpride and RB101, comparison with classical opioid maintenance treatments.

British journal of pharmacology 20070501

Amisulpride in the short-term treatment of depressive and physical symptoms in cancer patients during chemotherapies.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 20070501

Metabolic control in patients with schizophrenia treated with amisulpride or olanzapine.

International clinical psychopharmacology 20070501

Do differences in atypical antipsychotics matter in routine practice? Medication switch from olanzapine and risperidone to amisulpride.

International clinical psychopharmacology 20070501

Atypical antipsychotic therapy for treatment of schizophrenia in Hong Kong Chinese patients--a cost analysis.

International journal of clinical pharmacology and therapeutics 20070501

Amenorrhea after sertraline introduction in an amisulpride-treated patient with undiagnosed polycystic ovary disease.

Journal of clinical psychopharmacology 20070401

Development of tardive dyskinesia in a patient taking amisulpride.

Progress in neuro-psychopharmacology & biological psychiatry 20070330

[The benzamides tiapride, sulpiride, and amisulpride in treatment for Tourette's syndrome].

Der Nervenarzt 20070301

Amisulpride-induced hyperprolactinaemia is not reversed by addition of aripiprazole.

The international journal of neuropsychopharmacology 20070201

Transient hyperglycemia and decreased glucose tolerance during antipsychotic monotherapy with amisulpride.

Journal of clinical psychopharmacology 20070201

Remission of severely impaired subjective wellbeing in 727 patients with schizophrenia treated with amisulpride.

Acta psychiatrica Scandinavica 20070201

Amisulpride augmentation after the failure of citalopram for depression: a case report.

Journal of clinical pharmacy and therapeutics 20070201

Amisulpride-induced hyperprolactinemia is reversible following discontinuation.

Progress in neuro-psychopharmacology & biological psychiatry 20070130

Is the superior efficacy of new generation antipsychotics an artifact of LOCF?

Schizophrenia bulletin 20070101

Atypical antipsychotics and pituitary neoplasms in the WHO database.

Psychopharmacology bulletin 20070101

Outcomes in schizophrenia outpatients treated with amisulpride or olanzapine.

Pharmacopsychiatry 20070101

Comparison of clozapine-amisulpride and clozapine-quetiapine combinations for patients with schizophrenia who are partially responsive to clozapine: a single-blind randomized study.

Advances in therapy 20070101

Atypical antipsychotic drugs in the treatment of delusional parasitosis.

International journal of psychiatry in medicine 20070101

[Delusional bromosis: treatment with amisulpiride and olanzapine].

Annales de dermatologie et de venereologie 20070101

Neuroleptic malignant syndrome due to amisulpride in a patient with solvent-induced chronic toxic encephalopathy.

Clinical neuropharmacology 20070101

Amisulpride-induced neuroleptic malignant syndrome.

The Journal of neuropsychiatry and clinical neurosciences 20070101

Amisulpride-induced tardive dyskinesia.

Schizophrenia research 20061201

Efficacy of amisulpride in treating primary negative symptoms in first-episode psychosis: a pilot study.

Human psychopharmacology 20061201

Remission and relapse in the outpatient care of schizophrenia: three-year results from the Schizophrenia Outpatient Health Outcomes study.

Journal of clinical psychopharmacology 20061201

A double-blind randomised comparative trial of amisulpride versus olanzapine for 2 months in the treatment of subjects with schizophrenia and comorbid depression.

European psychiatry : the journal of the Association of European Psychiatrists 20061201

[The use of atypical antipsychotics in the long-term care of schizophrenia].

L'Encephale 20061201

Improvement of patient compliance after switching from conventional neuroleptics to the atypical neuroleptic amisulpride.

Journal of psychopharmacology (Oxford, England) 20061101

Early changes of plasma lipids during treatment with atypical antipsychotics.

International clinical psychopharmacology 20061101

The treatment of negative symptoms and deficit states of chronic schizophrenia: olanzapine compared to amisulpride and placebo in a 6-month double-blind controlled clinical trial.

Acta psychiatrica Scandinavica 20061101

The antipsychotic sultopride is overdosed--a PET study of drug-induced receptor occupancy in comparison with sulpiride.

The international journal of neuropsychopharmacology 20061001

Comparison of pramipexole and amisulpride on alertness, autonomic and endocrine functions in healthy volunteers.

Psychopharmacology 20060901

Amisulpride in the treatment of behavioural disturbances among patients with moderate to severe Alzheimer's disease.

Acta neurologica Scandinavica 20060801

Blockade of cue-induced brain activation of abstinent alcoholics by a single administration of amisulpride as measured with fMRI.

Alcoholism, clinical and experimental research 20060801

Haloperidol alone or in combination for acute mania.

The Cochrane database of systematic reviews 20060719

Cyclosporine A (CsA) affects the pharmacodynamics and pharmacokinetics of the atypical antipsychotic amisulpride probably via inhibition of P-glycoprotein (P-gp).

Journal of neural transmission (Vienna, Austria : 1996) 20060701

Improvement of tardive dyskinesia following amisulpride treatment.

Progress in neuro-psychopharmacology & biological psychiatry 20060601

[Endocrine side effects among psychiatric patients treated with antipsychotics].

Neuropsychopharmacologia Hungarica : a Magyar Pszichofarmakologiai Egyesulet lapja = official journal of the Hungarian Association of Psychopharmacology 20060601

A double-blind, randomised, controlled clinical trial of acetyl-L-carnitine vs. amisulpride in the treatment of dysthymia.

European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20060501

Ziprasidone and amisulpride effectively treat negative symptoms of schizophrenia: results of a 12-week, double-blind study.

International clinical psychopharmacology 20060501

Acute weight gain induced by amisulpride monotherapy in a first-episode schizophrenic patient.

International clinical psychopharmacology 20060501

Pergolide as adjuvant therapy to amisulpride in the treatment of negative and depressive symptoms in schizophrenia.

Pharmacopsychiatry 20060501

Amisulpride deliberate self-poisoning causing severe cardiac toxicity including QT prolongation and torsades de pointes.

The Medical journal of Australia 20060403

Switching to amisulpride monotherapy for treatment-resistant schizophrenia.

European psychiatry : the journal of the Association of European Psychiatrists 20060401

Sensorimotor gating and habituation of the startle response in schizophrenic patients randomly treated with amisulpride or olanzapine.

Biological psychiatry 20060315

Amisulpride treatment of clozapine-induced hypersalivation in schizophrenia patients: a randomized, double-blind, placebo-controlled cross-over study.

International clinical psychopharmacology 20060301

Gender aspects in the clinical treatment of schizophrenic inpatients with amisulpride: a therapeutic drug monitoring study.

Pharmacopsychiatry 20060301

Selective and sensitive determination of amisulpride in human plasma by liquid chromatography-tandem mass spectrometry with positive electrospray ionisation and multiple reaction monitoring.

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20060202

Amisulpride related tic-like symptoms in an adolescent schizophrenic.

Progress in neuro-psychopharmacology & biological psychiatry 20060101

[Treatment resistant schizophrenia, residual subtype: symptom improvement after additional treatment with amisulpride].

Psychiatrische Praxis 20060101

Amisulpride-induced tardive motor and phonic tics.

Clinical neuropharmacology 20060101

Delta power in sleep in relation to neuropsychological performance in healthy subjects and schizophrenia patients.

The Journal of neuropsychiatry and clinical neurosciences 20060101

[Amisulpride poisoning. A case report].

Therapie 20060101

Amisulpride versus risperidone treatment for behavioral and psychological symptoms in patients with dementia of the Alzheimer type: a randomized, open, prospective study.

Neuropsychobiology 20060101

Schizophrenia.

Clinical evidence 20051201

Amisulpride versus quetiapine for the treatment of delirium: a randomized, open prospective study.

International clinical psychopharmacology 20051101

Effects of dopaminergic and serotonergic manipulation on emotional processing: a pharmacological fMRI study.

NeuroImage 20051001

Amisulpride has no effect on plasma clozapine concentrations.

Journal of clinical psychopharmacology 20051001

Clinical implications of Brief Psychiatric Rating Scale scores.

The British journal of psychiatry : the journal of mental science 20051001

[Amisulpride in Huntington's disease].

Psychiatrische Praxis 20051001

Effects of novel antipsychotics, amisulpiride and aripiprazole, on maternal behavior in rats.

Psychopharmacology 20050901

Non-uniform blockade of intrastriatal D2/D3 receptors by risperidone and amisulpride.

Psychopharmacology 20050801

Amisulpride may help alcoholics in the early postdetoxification phase.

Journal of clinical psychopharmacology 20050801

Amisulpride and cardiomyopathy.

The Australian and New Zealand journal of psychiatry 20050801

Normalization of hyperprolactinaemia after withdrawal of a low dose of amisulpride.

Neuro endocrinology letters 20050801

Atypical anti-psychotics in the real world--a naturalistic comparative outcome study.

Scottish medical journal 20050801

Early-onset hypothesis of antipsychotic drug action: a hypothesis tested, confirmed and extended.

Biological psychiatry 20050615

Dopamine D3 modulation of locomotor activity and sleep in the nucleus accumbens and in lobules 9 and 10 of the cerebellum in the rat.

Progress in neuro-psychopharmacology & biological psychiatry 20050601

D2 receptor occupancy during high- and low-dose therapy with the atypical antipsychotic amisulpride: a 123I-iodobenzamide SPECT study.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine 20050601

Two cases of amisulpride overdose: a cause for prolonged QT syndrome.

Emergency medicine Australasia : EMA 20050601

Pheochromocytoma unmasked by amisulpride and tiapride.

The Annals of pharmacotherapy 20050501

Cost analysis of treating schizophrenia with amisulpride: naturalistic mirror image study.

Progress in neuro-psychopharmacology & biological psychiatry 20050501

An open-label study of amisulpride in the treatment of mania.

The Journal of clinical psychiatry 20050501

[Functional magnetic resonance tomography of central motor areas in schizophrenic patients].

Psychiatrische Praxis 20050401

Aripiprazole in a patient vulnerable to side effects.

The American journal of psychiatry 20050301

[From cradle to grave? Expectations from atypical antipsychotics].

Neuropsychopharmacologia Hungarica : a Magyar Pszichofarmakologiai Egyesulet lapja = official journal of the Hungarian Association of Psychopharmacology 20050301

Cognitive improvement in schizophrenic patients does not require a serotonergic mechanism: randomized controlled trial of olanzapine vs amisulpride.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20050201

Effectiveness of amisulpride augmentation of clozapine in a non-responder to either drug alone: a case report.

Acta psychiatrica Scandinavica 20050201

Pharmacological modulations in human cognitive processes: an fMRI study.

Journal of Nippon Medical School = Nippon Ika Daigaku zasshi 20050201

Reduction of side effects by combining clozapine with amisulpride: case report and short review of clozapine-induced hypersalivation-a case report.

Pharmacopsychiatry 20050101

Augmentation of clozapine with amisulpride: a promising therapeutic approach to refractory schizophrenic symptoms.

Pharmacopsychiatry 20050101

Augmentation with amisulpride for schizophrenic patients nonresponsive to antipsychotic monotherapy.

Clinical neuropharmacology 20050101

The effects of amisulpride on five dimensions of psychopathology in patients with schizophrenia: a prospective open-label study.

BMC psychiatry 20050101

[Fatal intoxication with amisulpride and presentation of organ distribution].

Archiv fur Kriminologie 20050101

Facilitation of enkephalins-induced delta-opioid behavioral responses by chronic amisulpride treatment.

Neuroscience 20050101

A typical mood stabilizers: a 'typical role for atypical antipsychotics.

Acta psychiatrica Scandinavica. Supplementum 20050101

Rhabdomyolysis and coma associated with amisulpride: a probable atypical presentation of neuroleptic malignant syndrome.

The Journal of clinical psychiatry 20041201

Hyperprolactinemia after low dose of amisulpride.

Neuro endocrinology letters 20041201

High striatal occupancy of D2-like dopamine receptors by amisulpride in the brain of patients with schizophrenia.

The international journal of neuropsychopharmacology 20041201

Schizophrenia.

Clinical evidence 20041201

Amisulpride-associated pedal edema.

European psychiatry : the journal of the Association of European Psychiatrists 20041101

EEG abnormalities under treatment with atypical antipsychotics: effects of olanzapine and amisulpride as compared to haloperidol.

Pharmacopsychiatry 20041101

[Rehospitalization rates of newly diagnosed schizophrenic patients on atypical neuroleptic medication].

Psychiatrische Praxis 20041101

A successful antipsychotic combination trial. Quo Vadis?

Acta psychiatrica Scandinavica 20041001

Amisulpride augmentation of clozapine: an open non-randomized study in patients with schizophrenia partially responsive to clozapine.

Acta psychiatrica Scandinavica 20041001

[Costs related to change to amisulpride in patients suffering from schizophrenia].

Neuropsychopharmacologia Hungarica : a Magyar Pszichofarmakologiai Egyesulet lapja = official journal of the Hungarian Association of Psychopharmacology 20041001

Prolactinemia is uncoupled from central D2/D3 dopamine receptor occupancy in amisulpride treated patients.

Psychopharmacology 20040901

A possible effect of amisulpride on a prolactinoma growth in a woman with borderline personality disorder.

Pharmacological research 20040901

[Psychotropics and weight gain].

Praxis 20040825

Identification of P-glycoprotein substrates and inhibitors among psychoactive compounds--implications for pharmacokinetics of selected substrates.

The Journal of pharmacy and pharmacology 20040801

Improvement of amisulpride-induced extrapyramidal symptoms with quetiapine.

The Australian and New Zealand journal of psychiatry 20040701

Usefulness of bromocriptine in the treatment of amisulpride-induced hyperprolactinemia: a case report.

Pharmacopsychiatry 20040701

Effects of amisulpride, risperidone and chlorpromazine on auditory and visual latent inhibition, prepulse inhibition, executive function and eye movements in healthy volunteers.

Journal of psychopharmacology (Oxford, England) 20040601

Transient hyperproinsulinemia during treatment with clozapine and amisulpride.

The Journal of clinical psychiatry 20040601

Successful treatment of Tourette's disorder with amisulpride.

The Annals of pharmacotherapy 20040501

Plasma amisulpride levels in schizophrenia or schizoaffective disorder.

European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20040501

Clozapine with amisulpride for refractory schizophrenia.

The American journal of psychiatry 20040501

Care maps: atypical antipsychotics. Introduction.

Nursing standard (Royal College of Nursing (Great Britain) : 1987) 20040501

Amisulpride is an 'atypical' antipsychotic associated with low weight gain.

Psychopharmacology 20040401

Amisulpride a selective dopamine antagonist and atypical antipsychotic: results of a meta-analysis of randomized controlled trials.

The international journal of neuropsychopharmacology 20040301

How do we choose between atypical antipsychotics? The advantages of amisulpride.

The international journal of neuropsychopharmacology 20040301

Lower risk for tardive dyskinesia associated with second-generation antipsychotics: a systematic review of 1-year studies.

The American journal of psychiatry 20040301

Dosage finding and outcome in the treatment of schizophrenic inpatients with amisulpride. Results of a drug utilization observation study.

Human psychopharmacology 20040301

Serotonin reuptake inhibitor provoked recurrence of alcohol hallucinosis--remission with additive amisulpride medication. A case report.

Pharmacopsychiatry 20040301

A double-blind, randomized comparative trial of amisulpride versus olanzapine for 6 months in the treatment of schizophrenia.

International clinical psychopharmacology 20040301

Combined use of amisulpride and clozapine for patients with treatment-resistant schizophrenia.

Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists 20040301

Combination of amisulpride and olanzapine in treatment-resistant schizophrenic psychoses.

European psychiatry : the journal of the Association of European Psychiatrists 20040201

[Current pharmacotherapy of schizophrenia].

Orvosi hetilap 20040118

Combination of clozapine and amisulpride in treatment-resistant schizophrenia--case reports and review of the literature.

Pharmacopsychiatry 20040101

[Effectiveness and tolerability of amisulpride in patients with schizophrenia: results of a 6-month open study].

Psychiatria polska 20040101

[The features of atypical neuroleptic amisulpride action].

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 20040101

Consensus on the use of substituted benzamides in psychiatric patients.

Neuropsychobiology 20040101

Impairment of visuospatial memory is associated with decreased slow wave sleep in schizophrenia.

Journal of psychiatric research 20040101

Amisulpride: a review of its use in the management of schizophrenia.

CNS drugs 20040101

[QT prolongation and second-generation antipsychotics: overdose and therapeutic dosage].

Therapie 20040101

THE LESSA (Lebanese Short-term Study with Amisulpride) STUDY a Phase IV clinical trial in acutely ill schizophrenic patients.

Le Journal medical libanais. The Lebanese medical journal 20040101

Schizophrenia.

Clinical evidence 20031201

How does the benzamide antipsychotic amisulpride get into the brain?--An in vitro approach comparing amisulpride with clozapine.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20031101

The antinociceptive effect of amisulpride in mice is mediated through opioid mechanisms.

European journal of pharmacology 20031008

Visual and auditory hallucinations with excessive intake of paroxetine.

Psychiatry and clinical neurosciences 20031001

Amisulpride: limbic specificity and the mechanism of antipsychotic atypicality.

Progress in neuro-psychopharmacology & biological psychiatry 20031001

Response of catatonic schizophrenia to amisulpride: a case report.

Canadian journal of psychiatry. Revue canadienne de psychiatrie 20030901

Amisulpride-induced mania in a patient with schizophrenia.

The British journal of psychiatry : the journal of mental science 20030801

Is regionally selective D2/D3 dopamine occupancy sufficient for atypical antipsychotic effect? an in vivo quantitative [123I]epidepride SPET study of amisulpride-treated patients.

The American journal of psychiatry 20030801

Amisulpiride augmentation in treatment resistant obsessive-compulsive disorder: an open trial.

Human psychopharmacology 20030801

Rapid high-performance liquid chromatographic measurement of amisulpride in human plasma: application to manage acute intoxication.

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20030605

Lack of effect of amisulpride on the pharmacokinetics and safety of lithium.

The international journal of neuropsychopharmacology 20030601

Pharmacological approaches to the management of schizophrenia.

The Medical journal of Australia 20030505

[Plasma prolactin level and incidence of adverse endocrinologic effects during therapy with atypical neuroleptics].

Psychiatrische Praxis 20030501

Automated determination of amisulpride by liquid chromatography with column switching and spectrophotometric detection.

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20030205

Respective roles of dopamine D2 and D3 receptors in food-seeking behaviour in rats.

Psychopharmacology 20030201

[Frontal dysfunctions in Huntington's disease -- neuropsychology and therapy].

Psychiatrische Praxis 20030101

Amisulpride versus risperidone in the treatment of schizophrenic patients: a double-blind pilot study in Taiwan.

Journal of the Formosan Medical Association = Taiwan yi zhi 20030101

Dose-related effects of amisulpride on five dimensions of psychopathology in patients with acute exacerbation of schizophrenia.

Journal of clinical psychopharmacology 20021201

Amisulpride vs. risperidone in chronic schizophrenia: results of a 6-month double-blind study.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20021201

Effects of amisulpride on consummatory negative contrast.

Behavioural pharmacology 20021201

Foreword. The clinical aspects of deficit in dopaminergic ways.

International clinical psychopharmacology 20021201

Dopaminergic deficit and the role of amisulpride in the treatment of mood disorders.

International clinical psychopharmacology 20021201

Dopaminergic deficit and the role of amisulpride in the treatment of schizophrenia.

International clinical psychopharmacology 20021201

Discriminative stimulus properties in rats of the novel antipsychotic quetiapine.

Experimental and clinical psychopharmacology 20021101

Acute psychosis after administration of bupropion hydrochloride (Zyban).

Pharmacopsychiatry 20021101

A comparison of paroxetine versus paroxetine plus amisulpride in the treatment of dysthymic disorder: efficacy and psychosocial outcomes.

Psychiatry research 20021010

Effects of sigma(1) receptor ligand MS-377 on D(2) antagonists-induced behaviors.

Pharmacology, biochemistry, and behavior 20021001

Catatonia and transcranial magnetic stimulation.

The American journal of psychiatry 20021001

Amisulpride does not prevent relapse in primary alcohol dependence: results of a pilot randomized, placebo-controlled trial.

Alcoholism, clinical and experimental research 20021001

Differential effects of high-dose amisulpride versus flupentixol on latent dimensions of depressive and negative symptomatology in acute schizophrenia: an evaluation using confirmatory factor analysis.

International clinical psychopharmacology 20020901

SPECT imaging, clinical features, and cognition before and after low doses of amisulpride in schizophrenic patients with the deficit syndrome.

Psychiatry research 20020820

Amisulpride improves depressive symptoms in acute exacerbations of schizophrenia: comparison with haloperidol and risperidone.

European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20020801

A comparison of paroxetine and amisulpride in the treatment of dysthymic disorder.

Journal of affective disorders 20020801

Effect of the amisulpride isomers on rat prolactinemia.

European journal of pharmacology 20020719

Carmoxirole is able to reduce amisulpride-induced hyperprolactinemia without affecting its central effect.

European journal of pharmacology 20020628

Effect of the amisulpride isomers on rat catalepsy.

European journal of pharmacology 20020524

[Atypical neuroleptics--a heterogenous group. Valuable option in acute psychoses].

MMW Fortschritte der Medizin 20020506

[QT prolongation and torsade de pointes--tachycardia in therapy with maprotiline].

Deutsche medizinische Wochenschrift (1946) 20020503

Tardive dyskinesias and antipsychotics: a review.

European psychiatry : the journal of the Association of European Psychiatrists 20020501

Switching to amisulpride due to hepatic complications.

European psychiatry : the journal of the Association of European Psychiatrists 20020501

Neuroleptic malignant syndrome due to atypical neuroleptics: three episodes in one patient.

Pharmacopsychiatry 20020501

Sub-chronic treatment with classical but not atypical antipsychotics produces morphological changes in rat nigro-striatal dopaminergic neurons directly related to 'early onset' vacuous chewing.

The European journal of neuroscience 20020401

Atypical antipsychotic medications and the treatment of schizophrenia.

The American journal of psychiatry 20020201

Amisulpride, an unusual 'atypical' antipsychotic: a meta-analysis of randomized controlled trials.

The American journal of psychiatry 20020201

Efficacy and safety of amisulpride 50 mg versus paroxetine 20 mg in major depression: a randomized, double-blind, parallel group study.

International clinical psychopharmacology 20020101

Social functioning and quality of life in the schizophrenic patient: advantages of amisulpride.

International clinical psychopharmacology 20020101

Comparative efficacy of SSRIs and amisulpride in burning mouth syndrome: a single-blind study.

The Journal of clinical psychiatry 20020101

Spotlight on amisulpride in schizophrenia.

CNS drugs 20020101

The substituted benzamides and their clinical potential on dysthymia and on the negative symptoms of schizophrenia.

Molecular psychiatry 20020101

Amisulpride for schizophrenia.

The Cochrane database of systematic reviews 20020101

Focus on amisulpride.